Evidence map›Paper›PMID 25628960›Full record

ReviewAmerican journal of clinical and experimental immunology2014

Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications.

Samantha F Friend, Francina Deason-Towne, Lisa K Peterson, Allison J Berger, Leonard L Dragone

Open access · greenAbstract readReview
In one paragraph

Review in American journal of clinical and experimental immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Post-Translational Regulation of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. CD4Frontiers in immunology · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Samantha F FriendDepartment of Pediatrics, University of Colorado School of Medicine Aurora, CO 80045, USA ; Integrated Department of Immunology, University of Colorado School of Medicine and National Jewish Health Denver, CO 80206, USA.
Francina Deason-TowneDepartment of Pediatrics, University of Colorado School of Medicine Aurora, CO 80045, USA ; Department of Biology, Regis University Denver, CO 80221, USA.
Lisa K PetersonDepartment of Pediatrics, University of Colorado School of Medicine Aurora, CO 80045, USA ; Integrated Department of Immunology, University of Colorado School of Medicine and National Jewish Health Denver, CO 80206, USA.
Allison J BergerTakeda Pharmaceuticals International Co. Cambridge, MA 02139, USA.
Leonard L DragoneDepartment of Pediatrics, University of Colorado School of Medicine Aurora, CO 80045, USA ; Integrated Department of Immunology, University of Colorado School of Medicine and National Jewish Health Denver, CO 80206, USA ; Division of Rheumatology, Colorado Children's Hospital Aurora, CO 80045, USA ; Since completing this study, Dr. Dragone has joined Genentech, a member of the Roche group. Genentech South San Francisco, CA 94090, USA.
National Jewish Health · USChildren's Hospital Colorado · USTakeda (Japan) · JPUniversity of Colorado Denver · US

Funding

Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Defining how TCR complex mediated signaling is regulated by neddylationR21AI097572 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DRAGONE, LEONARD LOUIS · 2012 to 2013
$343k
NIAID NIH HHS R21 AI097572NIAID NIH HHS T32 AI007405NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Post-translational protein modifications are a dynamic method of regulating protein function in response to environmental signals. As with any cellular process, T cell receptor (TCR) complex-mediated signaling is highly regulated, since the strength and duration of TCR-generated signals governs T cell development and activation. While regulation of TCR complex-mediated signaling by phosphorylation has been well studied, regulation by ubiquitin and ubiquitin-like modifiers is still an emerging area of investigation. This review will examine how ubiquitin, E3 ubiquitin ligases, and other ubiquitin-like modifications such as SUMO and NEDD8 regulate TCR complex-mediated signaling.

Indexed as

c-CblMLN4924NEDD8SLAPSUMOT cellubiquitin

Identifiers

PMID25628960
PMCPMC4299764
OpenAlexW129470696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.